Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS trial)

BACKGROUND: IBS affects 10-22% of the UK population. Abdominal pain, bloating and altered bowel habit affect quality of life, social functioning and time off work. Current GP treatment relies on a positive diagnosis, reassurance, lifestyle advice and drug therapies, but many suffer ongoing symptoms....

Descripción completa

Detalles Bibliográficos
Autores principales: Everitt, Hazel A, Moss-Morris, Rona E, Sibelli, Alice, Tapp, Laura, Coleman, Nicholas S, Yardley, Lucy, Smith, Peter W, Little, Paul S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998449/
https://www.ncbi.nlm.nih.gov/pubmed/21087463
http://dx.doi.org/10.1186/1471-230X-10-136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998449/
https://www.ncbi.nlm.nih.gov/pubmed/21087463
http://dx.doi.org/10.1186/1471-230X-10-136

Ejemplares similares